Risk factors for secondary epilepsy following febrile seizures in children: A meta-analysis

Jing Zhang1, Qiaomei Jing2, Shangbin Li2

  • 1Department of Neurology, First Affifiliated Hospital of Hebei Medical University, Hebei Medical University, Shijiazhuang 050000, China.

Epilepsy & Behavior : E&B
|September 22, 2024
PubMed

Insights

Identifying risk factors for secondary epilepsy in children with febrile seizures (FS) is crucial. Preterm birth, perinatal asphyxia, early seizure onset, and abnormal EEG/imaging are key risk factors for developing epilepsy after FS.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Clinical Genetics

Background:

  • Febrile seizures (FS) are common in children.
  • A subset of children with FS develop epilepsy.
  • Early identification of risk factors is vital for intervention.

Purpose of the Study:

  • To systematically assess risk factors for secondary epilepsy in children with febrile seizures.
  • To provide a foundation for timely clinical intervention and improved prognosis.

Main Methods:

  • Comprehensive literature search across multiple databases (PubMed, Embase, Web of Science, etc.) up to October 2023.
  • Meta-analysis of 23 studies involving 714 cases and 5269 controls.
  • Statistical analysis performed using Stata 15.0.

Main Results:

  • Significant risk factors identified include preterm birth, perinatal asphyxia, early age at first seizure (<12 months), low peak temperature (<39°C), and rapid onset of seizure after fever.
  • Complex febrile seizures (FS), prolonged duration (>15 min), multiple seizures, focal seizures, recurrent FS (≥2), neurodevelopmental abnormalities, and developmental delay are associated with increased epilepsy risk.
  • Family history of epilepsy or FS, abnormal electroencephalogram (EEG), and brain imaging abnormalities are also significant risk factors.

Conclusions:

  • This meta-analysis systematically identifies key risk factors for secondary epilepsy following febrile seizures in children.
  • Intervention strategies should target modifiable risk factors.
  • High-risk children, regardless of modifiable factors, require early detection and continuous follow-up to mitigate epilepsy risk.
Abstract

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
307
Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
181
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
292
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
266
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
341
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
645